152 related articles for article (PubMed ID: 8752126)
61. Lack of evidence for tachykinin NK1 receptor-mediated neutrophil accumulation in the rat cutaneous microvasculature by thermal injury.
Pintér E; Brown B; Hoult JR; Brain SD
Eur J Pharmacol; 1999 Mar; 369(1):91-8. PubMed ID: 10204686
[TBL] [Abstract][Full Text] [Related]
62. Chronic inflammation alters the contribution of neurokinin receptor subtypes to epithelial function in rat colon.
Appleyard CB; Morales M; Santiago C
Dig Dis Sci; 2008 Jan; 53(1):220-8. PubMed ID: 17510797
[TBL] [Abstract][Full Text] [Related]
63. Inhibition by SR 140333 of NK1 tachykinin receptor-evoked, nitric oxide-dependent vasodilatation in the hamster cheek pouch microvasculature in vivo.
Hall JM; Brain SD
Br J Pharmacol; 1994 Oct; 113(2):522-6. PubMed ID: 7530573
[TBL] [Abstract][Full Text] [Related]
64. Endogenous peptidergic modulation of perisynaptic Schwann cells at the frog neuromuscular junction.
Bourque MJ; Robitaille R
J Physiol; 1998 Oct; 512 ( Pt 1)(Pt 1):197-209. PubMed ID: 9729629
[TBL] [Abstract][Full Text] [Related]
65. Functional expression of the tachykinin NK1 receptor by floor plate cells in the embryonic rat spinal cord and brainstem.
Heath MJ; Lints TJ; Lee CJ; Dodd J
J Physiol; 1995 Jul; 486 ( Pt 1)(Pt 1):139-48. PubMed ID: 7562630
[TBL] [Abstract][Full Text] [Related]
66. Presence of NK1 receptors on a mucosal-like mast cell line, RBL-2H3 cells.
Cooke HJ; Fox P; Alferes L; Fox CC; Wolfe SA
Can J Physiol Pharmacol; 1998 Feb; 76(2):188-93. PubMed ID: 9635159
[TBL] [Abstract][Full Text] [Related]
67. Evidence for the presence of a septide-sensitive tachykinin receptor in the circular muscle of the guinea-pig ileum.
Maggi CA; Patacchini R; Meini S; Giuliani S
Eur J Pharmacol; 1993 Apr; 235(2-3):309-11. PubMed ID: 7685292
[TBL] [Abstract][Full Text] [Related]
68. Characterization of the binding of a potent, selective, radioiodinated antagonist to the human neurokinin-1 receptor.
Cascieri MA; Ber E; Fong TM; Sadowski S; Bansal A; Swain C; Seward E; Frances B; Burns D; Strader CD
Mol Pharmacol; 1992 Sep; 42(3):458-63. PubMed ID: 1383685
[TBL] [Abstract][Full Text] [Related]
69. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
[TBL] [Abstract][Full Text] [Related]
70. Pharmacology of tachykinin receptors on neurones in the ventral tegmental area of rat brain slices.
Seabrook GR; Bowery BJ; Hill RG
Eur J Pharmacol; 1995 Jan; 273(1-2):113-9. PubMed ID: 7537676
[TBL] [Abstract][Full Text] [Related]
71. Potencies of agonists acting at tachykinin receptors in the oestrogen-primed rat uterus: effects of peptidase inhibitors.
Fisher L; Pennefather JN
Eur J Pharmacol; 1997 Sep; 335(2-3):221-6. PubMed ID: 9369377
[TBL] [Abstract][Full Text] [Related]
72. Determination of the amino acid residues in substance P conferring selectivity and specificity for the rat neurokinin receptors.
Cascieri MA; Huang RR; Fong TM; Cheung AH; Sadowski S; Ber E; Strader CD
Mol Pharmacol; 1992 Jun; 41(6):1096-9. PubMed ID: 1377326
[TBL] [Abstract][Full Text] [Related]
73. Stimulation of angiogenesis by substance P and interleukin-1 in the rat and its inhibition by NK1 or interleukin-1 receptor antagonists.
Fan TP; Hu DE; Guard S; Gresham GA; Watling KJ
Br J Pharmacol; 1993 Sep; 110(1):43-9. PubMed ID: 7693287
[TBL] [Abstract][Full Text] [Related]
74. Facilitatory effects of selective agonists for tachykinin receptors on cholinergic neurotransmission: evidence for species differences.
Belvisi MG; Patacchini R; Barnes PJ; Maggi CA
Br J Pharmacol; 1994 Jan; 111(1):103-10. PubMed ID: 7516799
[TBL] [Abstract][Full Text] [Related]
75. The tachykinin NK1 receptor. Part I: ligands and mechanisms of cellular activation.
Quartara L; Maggi CA
Neuropeptides; 1997 Dec; 31(6):537-63. PubMed ID: 9574822
[TBL] [Abstract][Full Text] [Related]
76. Neurokinin receptor modulation of respiratory activity in the rabbit.
Bongianni F; Mutolo D; Cinelli E; Pantaleo T
Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
[TBL] [Abstract][Full Text] [Related]
77. Species differences between [3H] substance P binding in rat and guinea-pig shown by the use of peptide agonists and antagonists.
Fardin V; Garret C
Eur J Pharmacol; 1991 Aug; 201(2-3):231-4. PubMed ID: 1724651
[TBL] [Abstract][Full Text] [Related]
78. Neuropharmacological characterization of SR 140333, a non peptide antagonist of NK1 receptors.
Jung M; Calassi R; Maruani J; Barnouin MC; Souilhac J; Poncelet M; Gueudet C; Emonds-Alt X; Soubrié P; Brelière JC
Neuropharmacology; 1994 Feb; 33(2):167-79. PubMed ID: 8035902
[TBL] [Abstract][Full Text] [Related]
79. Effect of SR 140333, a selective NK1 antagonist, on antigen-induced oedema formation in rat skin.
Herbert JM; Bernat A
J Lipid Mediat Cell Signal; 1996 May; 13(3):223-32. PubMed ID: 8816986
[TBL] [Abstract][Full Text] [Related]
80. A new selective bioassay for tachykinin NK3 receptors based on inositol monophosphate accumulation in the guinea pig ileum.
Petitet F; Saffroy M; Torrens Y; Glowinski J; Beaujouan JC
Eur J Pharmacol; 1993 Oct; 247(2):185-91. PubMed ID: 7506659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
